Skip to content

Amyloidosis Hereditary Systemic 1 C2751492

Published: July 22, 2026Updated: August 20, 2026

A specific type of hereditary systemic amyloidosis, often caused by transthyretin gene mutations. It is passed down in families and affects multiple organs over time. Treatment may include gene-silencing drugs and transplant.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
other
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Shortness of breath

!

Palpitations

Fatigue

(other)

Generalized symptoms

(other)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Renal failure

(other)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Inotersen therapy

Subcutaneously administered antisense oligonucleotide therapy that reduces hepatic synthesis of mutant transthyretin in Val30Met and other TTR mutations.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Patisiran infusion

Lipid nanoparticle-delivered siRNA therapy administered intravenously to silence TTR gene expression, reducing circulating mutant protein levels.

medication

Additional treatment options

Liver transplant evaluation

Comprehensive assessment for liver transplantation candidacy in patients with progressive TTR amyloidosis, evaluating cardiac reserve and overall fitness for surgery.

procedure

Cardiac amyloidosis dietary support

Specific nutritional modifications including fluid restriction, sodium limitation, and protein adequacy for patients with cardiac TTR amyloid infiltration.

dietary

Acupressure for autonomic symptoms

Traditional technique targeting acupoints associated with nausea, orthostatic intolerance, and sleep disturbance commonly experienced in hereditary amyloidosis.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Amyloidosis Hereditary Systemic 1 C2751492?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Ando Y, Adams D, Benson MD, et al. Guidelines on the diagnosis and management of hereditary transthyretin amyloidosis. Amyloid. 2022;29(2):79-84.

guideline2022
2

Adams D, Gonzalez-Duarte A, Suhr OB, et al. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis. N Engl J Med. 2019;381(2):162-175.

clinical_trial2019
3

Benson MD, C在想R, Delamarre L, et al. Hereditary systemic amyloidosis: a comprehensive review. Lancet Neurol. 2021;20(5):352-366.

review2021
4

Gertz MA, Kyle RA, Therneau TM, et al. Meta-analysis of the efficacy of tafamidis in familial amyloid polyneuropathy: systematic review. Amyloid. 2023;30(1):15-25.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Amyloidosis Hereditary Systemic 1 C2751492. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy